Loading organizations...
Loading organizations...
Biopharmaceutical company developing cell therapies for liver diseases.
Promethera Biosciences has raised $131.7M across 6 funding rounds.
Promethera Biosciences has raised $131.7M in total across 6 funding rounds.
Promethera Biosciences has raised $131.7M in total across 6 funding rounds.
Promethera Biosciences's investors include Shinsei Capital Partners, Cyril Janssen, Marc Speeckaert, Olivier van der Rest, Ci:z Investment, Korea Investment Partners, MEDIPAL HOLDINGS CORPORATION, Mirae Asset Capital, Mitsui & Co. Global Investment, Six Snow, Shibuya Corporation, Shinsei Corporate Investment.
Promethera Biosciences has raised $131.7M across 6 funding rounds. Most recently, it raised $44.6M Series D in May 2019.